Iris Dallmann
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 15
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 4
-
- Chronic Myeloid Leukemia Treatments 5
- Multiple Myeloma Research and Treatments 4
- Co-authors
- Arnold Ganser (13 shared papers)Michaela Scherr (10 shared papers)Matthias Eder (8 shared papers)Jens Atzpodien (17 shared papers)Karin Battmer (5 shared papers)HUBERT POLIWODA (10 shared papers)Jan Buer (6 shared papers)Letizia Venturini (3 shared papers)
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (4 papers)Blood (3 papers)PLoS ONE (3 papers)Oncology (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Iris Dallmann
33 papers receiving 971 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 244
- Immunology 323
- Oncology 318
- Hematology 114
- Molecular Biology 438
Countries citing papers authored by Iris Dallmann
This map shows the geographic impact of Iris Dallmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Dallmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Dallmann more than expected).
Fields of papers citing papers by Iris Dallmann
This network shows the impact of papers produced by Iris Dallmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Dallmann. The network helps show where Iris Dallmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Dallmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 168 | |
| 2 | 1996 | 132 | |
| 3 | 2005 | 90 | |
| 4 | 2011 | 83 | |
| 5 | 1999 | 72 | |
| 6 | Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. | 1990 | 54 |
| 7 | 1994 | 52 | |
| 8 | Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes. | 1991 | 44 |
| 9 | 1994 | 30 | |
| 10 | 1993 | 30 | |
| 11 | 2003 | 26 | |
| 12 | 2014 | 25 | |
| 13 | 2002 | 22 | |
| 14 | 2004 | 18 | |
| 15 | 2016 | 17 | |
| 16 | 2019 | 15 | |
| 17 | 1993 | 14 | |
| 18 | 2002 | 14 | |
| 19 | 2011 | 12 | |
| 20 | Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens. | 1986 | 11 |
About Iris Dallmann
Iris Dallmann is a scholar working on Immunology, Hematology, Oncology, Cancer Research and Molecular Biology, having authored 34 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), MicroRNA in disease regulation (4 papers), Multiple Myeloma Research and Treatments (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Cancer Research (244 citations), Immunology (323 citations), Oncology (318 citations), Hematology (114 citations) and Molecular Biology (438 citations). Iris Dallmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Arnold Ganser, Michaela Scherr, Matthias Eder, Jens Atzpodien, Karin Battmer, HUBERT POLIWODA, Jan Buer, Letizia Venturini, Daniel Schaefer and Hartmut H. Kirchner. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, Blood, PLoS ONE, Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.